A New Imperative for Cardiac Wearables: Inclusivity, Interoperability, and Insight

Central to Ali’s perspective is the necessity of diverse data. “Most of the machine learning models were based on 65-year-old white males,” he explained. “So the previous data may not represent the cohort that you’re trying to apply these models to.” This imbalance extends to data management and integration. “There’s death by data,” Ali said. “Accurate data is key. MD doesn’t just mean medical doctor; it means make decisions.”Ali called for agnostic, interoperable dashboards that integrate with existing EMRs. Without this, providers face a flood of data with little guidance on clinical relevance. For more information visit here: https://www.sharepresentation.com/LSIUSA26/imperative-cardiac-wearables-inclusivity-interoperability-insight 

Comments

Post a Comment

Popular posts from this blog

Big Tech and Big Pharma: How Medtech Can Bridge the Gap

As technologies evolve and  healthcare innovation  accelerates, the traditional boundaries separating medtech, big tech, and big pharma are increasingly blurry — but the cultural and strategic gaps between them remain. At LSI USA ’25, panelists Juan-Pablo Mas (Action Potential Venture Capital), Nishant Doctor (Surf Therapeutics), and Jordi Parramon (Nexus NeuroTech Ventures) joined moderator Katie Elias to examine how medtech can better align with  big tech and big pharma  to drive innovation forward. The conversation centered on key differences in development strategy, investor expectations, and business timelines — critical challenges that arise when building partnerships or raising capital across sectors. As medtech companies seek broader platforms and more ambitious outcomes, understanding and navigating these differences becomes essential for effective cross-sector collaboration and long-term success. Understanding the Evidence Gap A major area of divergence bet...
Read more